Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgini

Showing results (651-660 of 678) with videos related to

Pageof 68
Sort By:
Neurobiology of Disease|July 2, 2014
α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent mannerGuowei Yin, Tomas Lopes da Fonseca, Sibylle E Eisbach, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2021
Identification of unprecedented ATP-competitive choline kinase inhibitorsFrancesca Quartieri, Marcella Nesi, Nilla R Avanzi, et al.
BMC Infectious Diseases|May 5, 2021
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 24, 2021
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, et al.
Molecular Cancer Therapeutics|February 10, 2012
NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignanciesBarbara Valsasina, Italo Beria, Cristina Alli, et al.
Journal of Ultrasound|July 9, 2020
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemicAndrea Smargiassi, Gino Soldati, Alberto Borghetti, et al.
Journal of Medicinal Chemistry|November 28, 2006
1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profileDaniele Fancelli, Jürgen Moll, Mario Varasi, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2018
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinomaM Persico, A Aglitti, A Aghemo, et al.
Cell Death & Disease|July 9, 2025
Estrogen rescues muscle regeneration impaired by DUX4 in a humanized xenograft mouse modelSilvia Maiullari, Giada Mele, Patrizia Calandra, et al.
Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.
Pageof 68

Showing results (651-660 of 678) with videos related to

Sort By:
Pageof 68
Neurobiology of Disease|July 2, 2014
α-Synuclein interacts with the switch region of Rab8a in a Ser129 phosphorylation-dependent mannerGuowei Yin, Tomas Lopes da Fonseca, Sibylle E Eisbach, et al.
Bioorganic & Medicinal Chemistry Letters|August 20, 2021
Identification of unprecedented ATP-competitive choline kinase inhibitorsFrancesca Quartieri, Marcella Nesi, Nilla R Avanzi, et al.
BMC Infectious Diseases|May 5, 2021
Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 24, 2021
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohortMaria Giovanna Quaranta, Luigina Ferrigno, Xhimi Tata, et al.
Molecular Cancer Therapeutics|February 10, 2012
NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignanciesBarbara Valsasina, Italo Beria, Cristina Alli, et al.
Journal of Ultrasound|July 9, 2020
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemicAndrea Smargiassi, Gino Soldati, Alberto Borghetti, et al.
Journal of Medicinal Chemistry|November 28, 2006
1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profileDaniele Fancelli, Jürgen Moll, Mario Varasi, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2018
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinomaM Persico, A Aglitti, A Aghemo, et al.
Cell Death & Disease|July 9, 2025
Estrogen rescues muscle regeneration impaired by DUX4 in a humanized xenograft mouse modelSilvia Maiullari, Giada Mele, Patrizia Calandra, et al.
Journal of Viral Hepatitis|December 11, 2020
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life settingMassimiliano Fabbiani, Andrea Lombardi, Marta Colaneri, et al.
Pageof 68